Last updated: 4 months ago
InflaRx N.V. Secures EU Approval for GOHIBIC®: A Game Changer for ARDS Treatment
InflaRx N.V. announces EU marketing authorization for GOHIBIC® to treat SARS-CoV-2-induced ARDS, marking a significant milestone in respiratory care. Learn more about this groundbreaking approval.